Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AVEO | BMY | AMGN | GILD | VRTX |
| Company | Aveo Pharmaceuticals | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.99 | 74.45 | 245.36 | 84.50 | 299.81 |
| High | 15.00 | 75.18 | 246.80 | 87.18 | 310.28 |
| Low | 14.99 | 74.23 | 243.45 | 84.50 | 299.72 |
| Last | 15.00 | 74.53 | 243.85 | 86.36 | 304.87 |
| Change | unch | +0.08 | -1.32 | +1.86 | +3.85 |
| % Change | unch | +0.11% | -0.54% | +2.20% | +1.28% |
| Volume | 247,800 | 7,112,700 | 2,196,900 | 7,611,100 | 1,295,500 |
| 20-Day Average Volume | 507,320 | 8,637,425 | 2,511,165 | 7,038,375 | 1,546,655 |
| Previous Close | 15.00 | 74.45 | 245.17 | 84.50 | 301.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.95 | 72.65 | 259.52 | 84.47 | 307.71 |
| 20-Day Raw Stochastic | 100.00% | 87.92% | 18.49% | 79.25% | 52.72% |
| 20-Day Relative Strength | 75.60% | 53.47% | 29.27% | 55.96% | 49.34% |
| Weighted Alpha | +144.00 | +8.20 | +2.20 | +45.30 | +25.50 |
| Today's Opinion | 100% Buy | 16% Buy | 24% Sell | 72% Buy | 64% Buy |
| Previous Opinion | 100% Buy | 16% Buy | 8% Sell | 40% Buy | 48% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 40% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.40% since 01/11/23 | +3.47% since 01/30/23 | -3.08% since 01/30/23 | +3.61% since 01/30/23 | -4.72% since 01/30/23 |
| Low | 14.97 on 01/12/23 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 299.72 on 02/06/23 |
| High | 15.00 on 01/19/23 | 75.18 on 02/06/23 | 253.86 on 01/31/23 | 87.18 on 02/06/23 | 325.19 on 01/31/23 |
| 1-Month | |||||
| %Chg | +0.60% since 12/19/22 | +2.10% since 01/06/23 | -11.39% since 01/06/23 | -1.95% since 01/06/23 | +5.05% since 01/06/23 |
| Low | 14.90 on 12/20/22 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 282.21 on 01/09/23 |
| High | 15.00 on 01/19/23 | 75.18 on 02/06/23 | 276.84 on 01/11/23 | 87.90 on 01/09/23 | 325.19 on 01/31/23 |
| 3-Month | |||||
| %Chg | +1.83% since 10/19/22 | -5.39% since 11/04/22 | -9.36% since 11/04/22 | +7.49% since 11/04/22 | -1.28% since 11/04/22 |
| Low | 14.67 on 10/20/22 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 79.51 on 11/07/22 | 282.21 on 01/09/23 |
| High | 15.00 on 01/19/23 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| 6-Month | |||||
| %Chg | +126.93% since 07/19/22 | +3.34% since 08/05/22 | -0.97% since 08/05/22 | +41.37% since 08/05/22 | +5.85% since 08/05/22 |
| Low | 6.61 on 07/20/22 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 60.81 on 08/08/22 | 276.57 on 09/26/22 |
| High | 15.00 on 01/19/23 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 521,445 | 158,292,608 | 130,817,560 | 105,983,616 | 77,269,128 |
| Shares Outstanding, K | 34,763 | 2,126,160 | 533,579 | 1,254,244 | 256,691 |
| Annual Sales | 42,300,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -53,340,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 30,450,000 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,334,300,000 |
| Last Quarter Net Income | -3,270,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 930,500,000 |
| 60-Month Beta | 1.00 | 0.43 | 0.63 | 0.39 | 0.47 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 11/07/22 | 1.82 on 02/02/23 | 4.09 on 01/31/23 | 1.67 on 02/02/23 | 4.01 on 10/27/22 |
| Latest Earnings Date | 03/13/23 | 02/02/23 | 01/31/23 | 02/02/23 | 02/07/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 03/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.45 | 13.94 | 11.20 | 23.00 |
